ALK-fusion-positive secondary ameloblastic carcinoma reached complete response after using alectinib

Siyi Li1, Rongrong Li1, Jing Xia2

  • 1Department of Oral & Maxillofacial-Head & Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, Shanghai, China; Shanghai Key Laboratory of Stomatology, Shanghai, China; National Clinical Research Center for Oral Diseases, Shanghai, China; Shanghai Key Laboratory of Stomatology, Shanghai, China.

Oral Oncology
|June 27, 2022
PubMed
Summary

No abstract available in PubMed .